baber/WOPTO huggingface dataset:
Patent JP-2000509380-A (JP)
Title: 殺虫組成物
IPC: A01N43/653
Filed: 1997-04-21
Abstract: (57)【要約】
本発明は少なくとも２種類の活性成分を担体と一緒に含んで成る相乗的に高められた作用を有する新規の作物防御活性成分混合物に関連し、ここで成分Ｉは１−〔〔２−（２，４−ジクロロフェニル）−４−プロピル−１，３−ジオキサラン−２−イル〕メチル〕−１Ｈ−１，２，４−トリアゾール（「プロピコナゾール」）(Ch．R．Worthing（編）：The Pesticide Manual、第９版、1991、頁724参照)であり、そして成分IIは５−メチル−１，２，４−トリアゾロ〔３，４−ｂ〕〔１，３〕ベンゾチアゾール（「トリシクラゾール」）(Ch．R．Worthing（編）：The Pesticide Manual、第９版、1991、頁846参照)であるか、又は各々はその塩又は金属錯化である。これらの混合物はピリキュラリア及びリゾクトニアに対して米を処理するのに極めて適する。
Patent JP-H11509513-A (JP)
IPC: G02B1/115
Filed: 1997-05-14
Abstract: PCT No. PCT/FR97/00857 Sec. 371 Date May 14, 1998 Sec. 102(e) Date May 14, 1998 PCT Filed May 14, 1997 PCT Pub. No. WO97/43224 PCT Pub. Date Nov. 20, 1997The invention relates to a glazing pane having an "A" antireflection coating on at least one of its external faces, which antireflection coating comprises a stack of layers of materials having alternately high and low refractive indices. At least some of the layers of the said stack are pyrolysed layers, especially the final layer.
Patent JP-2001518148-A (JP)
Title: ポリウレタンラテックス配合物から得られるポリウレタン裏地を有するカーペットの製造方法
IPC: D06N3/14
Filed: 1998-03-16
Abstract: (57)【要約】
本発明は、ポリウレタン又はポリウレタン形成性材料の水性分散体をカーペット基布の裏面に適用することにより製造される裏地を有するポリウレタン裏地付カーペットである。本発明によって、カーペット製造現場でポリウレタン裏地をそのモノマー成分から製造する必要がなくなる。連続法により本発明のポリウレタン裏地付カーペットを効率的に製造できる。
Patent JP-2002504810-A (JP)
Title: Ｃ型肝炎のｅ１およびｅ２短縮型ポリペプチドの細胞内生成
IPC: C12N15/09
Filed: 1998-05-06
Abstract: (57)【要約】
組換えにより生成されたＣ末端を切断されたE1およびE2ポリペプチドを細胞溶解物から得るための方法が開示される。細胞内で発現された、末端を切断された分予は、それらの分泌された対応物と比較して、改善した生物学的特性を示す。
Patent JP-2002512623-A (JP)
Title: アミノアルキルグルコサミンフォスフェート化合物ならびにアジュバントおよびイムノエフェクターとしてのそれらの用途
IPC: A61P37/04
Filed: 1998-05-07
Abstract: (57)【要約】
アジュバントおよびイムノエフェクターであるアミノアルキルグルコサミンフォスフェート化合物について開示し、請求の範囲を主張する。この化合物は2-デオキシ-2-アミノグルコースがアミノアルキル(アグリコン)基とグリコシド結合したものである。化合物はグルコサミン環の4位または6位の炭素がリン酸化されており、3つの3-アルカノイルオキシアルカノイル残基を含む。この化合物は、サイトカイン産生を刺激し、マクロファージを活性化するだけでなく、免疫化動物における抗体の産生を増大する。本発明の化合物をアジュバントおよびイムノエフェクターとして使用するための方法も開示する。
Patent JP-2002508728-A (JP)
IPC: B65B19/34
Filed: 1998-05-14
Abstract: The invention relates to an apparatus for applying drinking straws on prefabricated packaging containers. The apparatus includes a rotary drive means for advancing drinking straws which are guided in towards the drive means wrapped in protective envelopes, and continuously disposed as drinking straw belts. The apparatus also includes guides for drinking straws belts and drinking straws, and a device for separating drinking straws from the belt, and a device for applying the drinking straw on the side wall of the packaging container. The drive means of the apparatus routes continuously, and the device for separating drinking straws from the belt is disposed to accompany a part distance of the rotation of the drive means, this movement being realised by means of a cam and a cam roller cooperating therewith. The apparatus further includes a continuously driven conveyor on which the packaging containers are advanced so that one passes the drive means. The device for applying drinking straws to the side wall of the packaging container is disposed to accompany a part distance of the movement of the conveyor belt. The accompanying movement is realised in that the applicator device is journaled in two eccentric shafts.
Patent NZ-195215-A (NZ)
Title: Automatic gain control circuit with gain freeze facility
Inventor: GALPIN R K P
IPC: H03G3/20
Filed: 1980-10-09
Abstract: In high speed high quality modems it is important to be able to preserve the gain value for the automatic gain control system during breaks in transmission to permit rapid resumption of normal operation. The a.g.c. circuit comprises a basic a.g.c. transistor amplifier whose emitter-collector conductance is varied by a control voltage derived from the envelope of the amplifier output voltage which is well known. The invention involves the use of a digital-to-analog converter which is controlled by a digital-up-down counter. The counter is controlled by a window comparator which compares the rectified output voltage of the amplifier with a reference voltage level and upper and lower limits. If the output voltage exceeds either limit, the counter is enabled and the appropriate up or down indication is given. The counter is then clocked to change the drive to the d-to-a converter which thereby changes the conductance of the a.g.c. transistor. The state of the up down counter will be used to maintain the a.g.c. at the last level in the event of a transmission break by inhibiting the clock for the counter.
Patent NZ-196648-A (NZ)
Title: Web coating method and apparatus: web moves in same direction as applicator roll surface
Inventor: KEEP G S
IPC: B41C1/18
Filed: 1981-03-27
Abstract: In an offset gravure web coating method and apparatus, coating composition is applied from a gravure roll to a transfer roll, thence to an applicator roll, and finally to the web. The web moves in the same direction as the applicator roll surface. The ratio of the speed of the applicator roll surface to that of the web is preferably not greater than 1:1. The method and apparatus afford improved coating patterns at low wet coatweights.
Patent NZ-211885-A (NZ)
Title: Benzodioxinopyrrole derivatives and pharmaceutical compositions containing such
Inventor: KITCHIN J
IPC: A61P1/12
Filed: 1985-04-24
Abstract: Compounds of the general formula (I)(R is H, alkyl, alkenyl, alkynyl, cycloalkyl, aralkyl or CHO, R' and R<sup>2</sup> are independently halogen, alkyl, alkoxy, hydroxyl, cyano, nitro or -NR<sup>3</sup>R<sup>4</sup> where R<sup>3</sup> and R<sup>4</sup> are independently H or alkyl and R<sup>2</sup> may be H) and their salts have selective α<sub>2</sub>- adrenoreceptor antagonist action.The compounds may be prepared by amination of compounds of the general formula (II)(where R<sup>1</sup> and R<sup>2</sup> are as defined above and X is a leaving group)
Patent NZ-227944-A (NZ)
Title: Synergistic pharmaceutical composition of a hybrid interferon and a muramylpeptide
Inventor: GANGEMI J DAVID
IPC: A61P35/00
Filed: 1989-02-10
Abstract: Described is a synergistic pharmaceutical combination preparation comprising as component A a hybrid  alpha -interferon the structure of which is derived from human interferon- alpha -D and - alpha -B gene fragments and as component B a muramylpeptide. Said preparation can be used for treating viral diseases or reducing the formation of metastases of certain tumors.
Patent NZ-228094-A (NZ)
Title: Transmembranally administerable compositions containing bioaffecting agent and gelling agent
Inventor: MAJID MAHJOUR
IPC: A61K9/00
Filed: 1989-02-22
Abstract: The invention comprises a two-ply composite laminate for transmembranal administration of an active medicament consisting of   A.) a layer I comprising a component A consisting of a solvent and an active medicament incorporated in a partly cured elastomer, B.) a layer II laminated onto layer I comprising a component B consisting of a solvent and an active medicament e.g. THA (tacrine) incorporated in a macroporous slab with a pore size of 10 to 100  mu m. h
Patent NZ-230856-A (NZ)
Title: Production of human tissue type plasminogen activator (tpa) under conditions of increased osmotic pressure
Inventor: SHOICHIRO MIYAHARA
IPC: C12N5/00
Filed: 1989-10-02
Abstract: Human tissue type plasminogen activator (tPA) which is effective as a therapeutic agent is obtained at a high concentration by increasing the osmotic pressure of the cell culture medium or tPA producing medium using bicarbonate ion up to at least 350 milliosmole/liter optionally also supplementing the medium with an antiplasmin agent. Single-chain tPA is produced at a high concentration accordingly.
Patent NZ-234344-A (NZ)
Title: Cationic latex paint composition
Inventor: VAN RHEENEN PAUL RALPH
IPC: C09D7/45
Filed: 1990-07-03
Abstract: A paint composition comprising cationic latex polymeric binder, pigment and selective cationic pigment dispersant is disclosed. The paint compositions, which demonstrate the advantages of a water-based system, also exhibit excellent stain blocking, corrosion resistance, water sensitivity resistance and adhesion to wood and alkyd surfaces which are competitive in performance with conventional solvent based alkyd primers.
Patent NZ-264719-A (NZ)
Title: Injection device with a cannula and an advancer unit having a cannula holder to propel the cannula
Inventor: CIRELLI GIORGIO
IPC: A61M/
Filed: 1994-10-18
Abstract: The device is intended to introduce a solution of active substance into a patient, and it possesses means for fastening on the skin and a cannula (9). Before use, the cannula is held in a retracted position by a holding and triggering mechanism (14) and after triggering it is shot into the skin of the patient. A connection (6) connected to the back of the cannula is intended to connect the cannula to an active substance reservoir. <IMAGE>
Patent NZ-271077-A (NZ)
Title: Combination of a progestin and nitric oxide synthase substrate and/or donor for treating preeclampsia and preterm labour
Inventor: GARFIELD ROBERT E
IPC: A61K31/57
Filed: 1994-07-18
Abstract: Preeclampsia and preterm labor in a pregnant female mammal are treated by administering thereto a combination of a progestin and a nitric oxide synthase substrate, a nitric oxide donor or both, optionally in further combination with one or more of a cyclooxygenase inhibitor, a PGI2-mimetic, a thromboxane (TXA2) inhibitor, a compound possessing TXA2-agonistic and TXA2-inhibiting properties, a compound possessing TXA2-antagonistic and PGI2-memetic activities, and a TXA2 antagonist.
Patent NZ-328660-A (NZ)
Title: Non swabable medicament for treating muscle soreness and muscle tying up symptoms in racehorses comprising potassium iodide and ammonium chloride
Inventor: HOOPER OSWALD EDMONDS
IPC: A61K33/18
Filed: 1997-09-02
Abstract: A non swabable medicament suitable for racehorses for avoiding or treating muscle soreness and/or muscle tying up symptoms comprising Potassium iodide (2g/100ml) and Ammonium chloride (2g/100ml).  The medicament can also include methyl paraben and isopropyl paraben. Addition to 328660
Patent NZ-329246-A (NZ)
Title: Pharmaceutical composition comprising one or more eutectic mixture of lidocaine and prilocaine, surfactants, water and a taste masking agent
Inventor: BRODIN ARNE
IPC: A61K31/167
Filed: 1997-04-01
Abstract: A composition comprising one or more local anaesthetics (such as lidocaine and prilocaine) in oil form, one or more surfactants, water and optionally a taste masking agent. The composition is advantageously used as a local anaesthetic for pain relief within the oral cavity.
Patent NZ-329360-A (NZ)
Title: Immortalised retinal derived cell lines capable of being implanted in the retina and carrying a therapeutic substance to the eye and the central nervous system and other applications of the cell thereof
Inventor: GREENWOOD JOHN
IPC: C12N15/09
Filed: 1997-04-18
Abstract: The invention features immortalized retina-derived (retinal endothelial or retinal epithelial pigmentary) cell lines capable of being implanted in the retina and of carrying a therapeutic substance to the eye and to the central nervous system. Such lines can also be used as a model for studying blood central nervous system interfaces. These lines are derived from primary retinal cultures selected from the group consisting of primary retinal endothelial cells and primary retinal epithelial cells, comprise a nucleic acid fragment containing at least one immortalizing fragment of a heat-sensitive viral oncogene, which nucleic fragment is optionally associated with at least one selection gene, and have the morphological characteristics and at least the expression characteristics of the surface antigens of corresponding primary cultures.
Patent NZ-330843-A (NZ)
Title: The use of a chelating agent in a peroxygen bleach containing composition to improve disinfecting properties
Inventor: ROMANO NICOLETTA
IPC: A01N65/00
Filed: 1997-01-08
Abstract: The use of a chelating agent in an antimicrobial active disinfectant composition comprising a peroxygen bleach for disinfection of surfaces.
Patent NZ-332365-A (NZ)
Title: Screening for genetic polymorphism for Vitamin D receptor gene for predisposition for osteoarthritis
Inventor: SPECTOR TIMOTHY DAVID
IPC: C12Q1/6883
Filed: 1997-04-21
Abstract: A method of diagnosis for predisposition or susceptibility to osteoarthritis comprising of determining the presence or absence of a polymorphic risk version of a vitamin D receptor gene in an animal. The polymorphic risk version of the gene being one that does not contain a cleavage site for restriction enzyme TaqI. The method comprises of using PCR techniques to amplify a fragment of exon 9 of the vitamin D receptor gene. The PCR primers used are: 1. CAGAGCATGGACAGGGAGCAAC (3') 2. GCAACTCCTCATGGCTGAGGTCTC (3') to amplify a 740 base pair fragment of exon 9 of Vitamin D receptor gene.
Patent NZ-335278-A (NZ)
Title: A female coupling member for use with a male coupling member for low spill quick coupling
Inventor: WELLS MICHAEL P
IPC: F16L37/34
Filed: 1997-09-16
Abstract: A female coupling member for use with a male coupling member comprises: (a) a body having a passageway extending along an axis from a receiving end to an opposing end with the receiving end (1) sized to receive the male coupling member body portion and (2) defining an opening to the passageway, a first inwardly facing cylindrical wall section extending axially inwardly from the receiving end and sized to permit movement of the abutment therethrough, a second inwardly facing cylindrical wall section having a size to receive the male coupling member cylindrical wall portion in close relationship; (b) a sleeve having an engagement end and an opposing end positioned in the passageway for axial movement therein from a forward position in the vicinity of the receiving end to a retracted position closer to the opposing end; (c) a stem valve mounted on the body and extending through the sleeve and having an enlarged head sealingly engageable with the sleeve, the sleeve and the stem valve being relatively moveable between an engaged, closed position and an open position, the enlarged head having a cavity sized to receive the nose when the male coupling member entrance end engages the sleeve engagement end and (d) a spring yieldingly urging the sleeve toward the forward position. A sealing ring is positioned on one of the stem valve enlarged head and the sleeve and the stem valve extends axially between the enlarged head and a second end mounted in an aperture of a web position in the body. The stem valve has a first shoulder on one side of the web and a second shoulder on the opposite side of the web.  The shoulders are spaced apart a distance greater than the thickness of the web sufficient to permit the stem to float axially to compensate for stack up of tolerances of the body, the sleeve and stem valve and assure a seal between the sealing ring and the stem valve enlarged head. The male coupling member has (1) a body portion with an entrance end including an annular surface defining an opening communicating with an axial passageway and (2) an axially extending stem valve axially movable in the axial passageway between a closed position and an open position which includes a nose with extends through the opening and outwardly from the annular surface when the stem valve is in the closed position.
Patent NZ-337227-A (NZ)
Title: Electrosurgical instrument, with sharp edges to concentrate electric field
Inventor: GREEP DARCY W
IPC: A61B18/12
Filed: 1998-06-02
Abstract: An electrosurgical instrument has a conducting electrode 22' with an insulating coating 20' for delivering RF energy to tissue by capacitative coupling.  The electrode has a sharp edge 25 which concentrates the electric field to increase the efficiency of the electrode.  The edge may protrude slightly beyond the insulating coating.  The coating 20' may be diamond, or a fluorinated hydrocarbon.
Patent NZ-502201-A (NZ)
Title: Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors
Inventor: JENNER PAUL NORMAN
IPC: A61K31/343
Filed: 1998-07-14
Abstract: The use of SSRI or pharmaceutically acceptable salt  in the treatment and/or prevention of cardiac disorders associated with the pathogenesis of thrombosis.
Patent NZ-507416-A (NZ)
Title: Wet granulation method for generating granules
Inventor: PHINNEY ROBIN
IPC: C05G5/12
Filed: 1999-04-08
Abstract: A method for granulating feedstock, comprising the steps of: providing a first feedstock of a specified size (10); providing a binder material having a moisture content; contacting first feedstock with binder; forming a pre-moistened mixture of binder and first feedstock having a moisture content (14), introducing the pre-moistened mixture onto a pan granulator (28) containing second feedstock differently sized from the first feedstock; maintaining a new moisture content and forming first granules on pan (28) directly from contact of the pre-moistened mixture and said second feedstock in the absence of seed material.
Patent NZ-508798-A (NZ)
Title: Pet food composition comprising L-carnitine, and its use in the manufacture of pet food products for promoting weight loss and/or increasing lean body mass and/or enhancing the satiety and decreasing voluntary food intake in overweight dogs
Inventor: SUNVOLD GREGORY DEAN
IPC: A23K1/16
Filed: 1999-06-22
Abstract: A process for feeding a pet food supplement or diet  to an  overweight  canine for the purpose of  promoting  weight loss,  and/or  increasing lean body mass,  and/or  enhancing the  satiety  of the animal is provided. The  supplement  or diet  contains an effective amount of L-carnitine from about 1  to  100 mg/kg of the diet for a time sufficient to effect a reduction in the weight of the animal.
Patent NZ-510442-A (NZ)
Title: Immunogenic liposome composition comprising vesicle forming lipids and an antigenic construct with antigenic domains and a hydrophobic domain plus methods of making the composition
Inventor: PERRY L JEANNE
IPC: A61P31/16
Filed: 1999-09-22
Abstract: Described is an immunogenic liposome composition comprising vesicle-forming lipids and an antigenic construct comprising one or more antigenic determinants and a hydrophobic domain.
Patent NZ-512184-A (NZ)
Title: Aromatic heterocycle compounds having HIV integrase inhibiting activities
Inventor: FUJISHITA TOSHIO
IPC: C07D403/06
Filed: 1999-12-17
Abstract: A compound of the formula (I), a tautomer, a prodrug, a pharmaceutically acceptable salt or a hydrate thereof that has an inhibitory activity against an integrase is disclosed wherein: X is hydroxy, protected hydroxy or optionally substituted amino; Y is COORA wherein RA is hydrogen or ester residue, -CONRBRC wherein RB and RC each is independently hydrogen or amide residue, optionally substituted aryl or optionally substituted heteroaryl; and A1 is optionally substituted heteroaryl; provided that a compound wherein Y and/or A1 is optionally substituted indol-3-yl is excluded.
Patent NZ-515232-A (NZ)
Title: IL-8 receptor antagonists
Inventor: BRYAN DEBORAH L
IPC: C07C279/28
Filed: 2000-06-16
Abstract: This invention relates to novel compounds of Formula (I), pharmaceutical compositions and their use in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).
Patent NZ-515717-A (NZ)
Title: Process to produce recombinant human mannan-binding lectin and its use in treatments of disorders of the immune system
Inventor: JENSENIUS JENS CHRISTIAN
IPC: A61P35/00
Filed: 2000-05-10
Abstract: A process for producing a human recombinant mannan binding lectin (MBL) composition having a size distribution profile at least 50 % of the oligomers have an apparent molecular weight higher than 200kDa comprises the steps of: -  preparing a gene expession construct encoding human MBL peptide or a functional equivalent thereof, -  transforming a hot cell culture with the construct, -  cultivating he host cell culture, thereby obtaining expression and secretion of the polypeptide into the culture medium, -  subjecting the culture medium to affinty chromatography using a carbohydrate-derivatized matrix having affinity for MBL. The underivatized matrix has substantially no affinity for MBL and whereby the carbohydrate-derivatized matrix has at least a two-fold greater affinity for tetramers, pentamers and/or hexamers of MBL subunit than for dimers of MBL subunit; -  obtaining an eluate compising the human recombinant MBL composition Also described is a gene expression construct encoding a recombinant human mannan -binding lectin polypeptide.
Patent NZ-516264-A (NZ)
Title: Cancer antigens CA125 (multiple epitote) recognised by OC125, M11, B43.13, B27.1, where B43.13 is used as a binding agent to elicit host immune response as a vaccination method against cancer
Inventor: MADIYALAKAN RAGUPATHY
IPC: A61K39/395
Filed: 1996-05-15
Abstract: Methods and compositions for initiating and/or enhancing an immune response include contacting a binding reagent with a soluble antigen, wherein the binding reagent-antigen pair generates an immune response to the antigen.  A medicament, of a binding agent that binds specifically to a first binding site on a multi-binding site antigen, that is present in the host's serum, and does not elicit an effective immune response.  The binding agent is exclusive of B43.13, and the response of administering the medicament is a therapeutic host immune response against a second binding site on the antigen where the antigen is a soluble tumour-associated antigen.
Patent NZ-517129-A (NZ)
Title: Apparatus for obtaining biological samples
Inventor: LURIE ISRAEL RALEIGH
IPC: A61B10/00
Filed: 2000-08-11
Abstract: A device for collection of a fluid sample, particularly a biological sample from an internal cavity of a mammal, comprises a barrel (3) having an opening (4) at one end thereof, a plunger (2) operable axially within the barrel, the barrel and the plunger defining a fluid chamber (7) having a volume which varies on axial movement of the plunger within the barrel, and a hollow, elongate tube (1) extending from the fluid chamber through the opening in the barrel, the tube being in operative engagement with the plunger for axial movement to extend and retract the tube within respect to the barrel on axial movement of the plunger, and the tube being in fluid communication with the fluid chamber to provide a fluid flow path to and from the fluid chamber through the hollow tube. A method for collection of a fluid sample from an internal cavity of a mammal is also disclosed.
Patent NZ-517558-A (NZ)
Title: Coffee aroma recovery process
Inventor: FURRER MARC
IPC: A23F5/48
Filed: 2000-08-21
Abstract: A process for the recovery of aroma components from coffee grounds. Coffee grounds are placed in a mixer. The coffee grounds are wet, heated, and exposed to decreased pressure to provide aroma containing gas containing aroma components. From 40% to 95% of the aroma components in the coffee grounds are collected from the aroma containing gas. The heating is to a temperature of about 50oC to about 95oC if heating is stopped or reduced before exposing the coffee grounds to decreased pressure, or to a temperature of 70 oC to 95oC if heating is maintained while exposing the coffee grounds to decreased pressure. The aroma components may be added to concentrated coffee extract prior to the drying of the extract. The coffee powder produced has much increased and improved aroma and flavour.
Patent NZ-517872-A (NZ)
Title: Multidrug efflux pumps
Inventor: BURNIE JAMES PETER
IPC: A61P31/04
Filed: 2000-10-09
Abstract: Sequence ID's for inhibitors of microorganism multidrug efflux pumps, and thus use in antimicrobial compositions.